FASLODEX Trademark of AstraZeneca (UK) Limited - Serial Number 75934871

FASLODEX Trademark

Trademark Overview

On Friday, March 3, 2000, a trademark application was filed for FASLODEX with the United States Patent and Trademark Office. The USPTO has given the FASLODEX trademark a serial number of 75934871. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 29, 2011. This trademark is owned by AstraZeneca (UK) Limited. The FASLODEX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the prevention and/or treatment of cancer, carcinomas, sarcomas and tumors of any description; pharmaceutical preparations for the treatment of gynecological disorders

General Information

Serial Number	75934871
Word Mark	FASLODEX
Filing Date	Friday, March 3, 2000
Status	710 - CANCELLED - SECTION 8
Status Date	Friday, July 29, 2011
Registration Number	2914736
Registration Date	Tuesday, December 28, 2004
Mark Drawing	3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition Date	Tuesday, August 28, 2001

Trademark Statements

Goods and Services	pharmaceutical preparations for the prevention and/or treatment of cancer, carcinomas, sarcomas and tumors of any description; pharmaceutical preparations for the treatment of gynecological disorders
Lining/Stippling Statement	The drawing is lined for the colors yellow and purple.

Classification Information

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	006, 018, 044, 046, 051, 052
Class Status Code	2 - Sec. 8 - Entire Registration
Class Status Date	Friday, July 29, 2011
Primary Code	005
First Use Anywhere Date	Monday, May 20, 2002
First Use In Commerce Date	Monday, May 20, 2002

Trademark Owner History

Party Name	AstraZeneca (UK) Limited
Party Type	30 - Original Registrant
Legal Entity Type	16 - Limited Liability Company
Address	London, W1Y 6LN

Party Name	AstraZeneca (UK) Limited
Party Type	20 - Owner at Publication
Legal Entity Type	16 - Limited Liability Company
Address	London, W1Y 6LN

Party Name	AstraZeneca (UK) Limited
Party Type	10 - Original Applicant
Legal Entity Type	16 - Limited Liability Company
Address	London, W1Y 6LN

Trademark Events

Event Date	Event Description
Friday, July 29, 2011	CANCELLED SEC. 8 (6-YR)
Tuesday, July 31, 2007	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 31, 2007	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 28, 2004	REGISTERED-PRINCIPAL REGISTER
Tuesday, October 26, 2004	LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, October 22, 2004	ASSIGNED TO LIE
Friday, October 15, 2004	ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 8, 2004	AMENDMENT FROM APPLICANT ENTERED
Thursday, September 23, 2004	CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 23, 2004	PAPER RECEIVED
Thursday, July 22, 2004	NON-FINAL ACTION MAILED
Thursday, July 15, 2004	ASSIGNED TO EXAMINER
Monday, June 28, 2004	STATEMENT OF USE PROCESSING COMPLETE
Monday, June 28, 2004	USE AMENDMENT FILED
Monday, June 28, 2004	TEAS STATEMENT OF USE RECEIVED
Monday, June 7, 2004	EXTENSION 5 GRANTED
Thursday, May 20, 2004	EXTENSION 5 FILED
Friday, May 28, 2004	CASE FILE IN TICRS
Friday, May 28, 2004	CASE FILE IN TICRS
Thursday, May 20, 2004	TEAS EXTENSION RECEIVED
Tuesday, December 2, 2003	EXTENSION 4 GRANTED
Thursday, November 20, 2003	EXTENSION 4 FILED
Thursday, November 20, 2003	TEAS EXTENSION RECEIVED
Friday, June 6, 2003	EXTENSION 3 GRANTED
Tuesday, May 20, 2003	EXTENSION 3 FILED
Tuesday, May 20, 2003	TEAS EXTENSION RECEIVED
Wednesday, January 22, 2003	EXTENSION 2 GRANTED
Wednesday, November 13, 2002	EXTENSION 2 FILED
Wednesday, November 13, 2002	PAPER RECEIVED
Tuesday, March 12, 2002	EXTENSION 1 GRANTED
Thursday, February 21, 2002	EXTENSION 1 FILED
Tuesday, November 20, 2001	NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 28, 2001	PUBLISHED FOR OPPOSITION
Wednesday, August 8, 2001	NOTICE OF PUBLICATION
Wednesday, March 21, 2001	APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 12, 2001	EXAMINER'S AMENDMENT MAILED
Thursday, March 1, 2001	NON-FINAL ACTION MAILED
Monday, October 23, 2000	CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 16, 2000	CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 11, 2000	NON-FINAL ACTION MAILED
Friday, August 11, 2000	ASSIGNED TO EXAMINER
Tuesday, August 8, 2000	ASSIGNED TO EXAMINER

Related Keywords

faslodex pharmaceutical treatment preparations description gynecological tumors disorders carcinomas prevention cancer